Infliximab Discontinuation in Crohn's Disease Patients in Stable Remission On Combined Therapy with Immunosuppressors: A Prospective Ongoing Cohort Study

被引：0
|
作者：
Louis, Edouard
Vernier-Massouille, Gwenola
Grimaud, Jean-Charles
Bouhnik, Yoram
Laharie, David
Dupas, Jean-Louis
Pillant, Helene
Picon, Laurence
Veyrac, Michel
Flamant, Mathurin
Savoye, Guillaume
Jian, Raymond
De Vos, Martine
Paintaud, Gilles
Piver, Eric
Colombel, Jean-Frederic
Mary, Jean-Yves
Lemann, Marc
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A146 / A146
页数：1
相关论文
共 50 条
  • [1] Discontinuation of infliximab in patients with Crohn's disease on combination therapy
    Hindson, Jordan
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (03) : 131 - 131
  • [2] Discontinuation of infliximab in patients with Crohn’s disease on combination therapy
    Jordan Hindson
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 131 - 131
  • [3] Prediction of Sustained Remission After Discontinuation of Infliximab in Patients With Crohn's Disease
    Papamichail, Konstantinos
    Casteele, Niels Vande
    Hauenstein, Scott
    Princen, Fred
    Singh, Sharat
    Ferrante, Marc
    van Assche, Gert A.
    Rutgeerts, Paul J.
    Gils, Ann
    Vermeire, Severine
    GASTROENTEROLOGY, 2014, 146 (05) : S457 - S457
  • [4] Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation
    Cathy Lu
    Alistair Waugh
    Robert J Bailey
    Raeleen Cherry
    Levinus A Dieleman
    Leah Gramlich
    Kata Matic
    Mario Millan
    Karen I Kroeker
    Daniel Sadowski
    Christopher W Teshima
    Dennis Todoruk
    Clarence Wong
    Karen Wong
    Richard N Fedorak
    World Journal of Gastroenterology, 2012, (36) : 5058 - 5064
  • [5] Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation
    Lu, Cathy
    Waugh, Alistair
    Bailey, Robert
    Cherry, Raeleen
    Dieleman, Levinus A.
    Gramlich, Leah
    Matic, Kata
    Millan, Mario
    Kroeker, Karen I.
    Sadowski, Daniel
    Teshima, Christopher W.
    Todoruk, Dennis
    Wong, Clarence
    Wong, Karen
    Fedorak, Richard N.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (36) : 5058 - 5064
  • [6] Discontinuation of Infliximab Therapy in patients with Crohn's disease: outcome and risk factors
    Chen, Zhao
    Xiang, Cheng
    Hu, Huiqin
    Jiang, Bo
    Qiu, Chen
    Wang, Guozhen
    Wang, Xinying
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 154 - 154
  • [7] Meta-Analysis- Maintenance of Remission Following Discontinuation of Infliximab in Patients With Crohn's Disease
    Sofi, Aijaz
    Ali, Abdulmonam
    Khuder, Sadik A.
    Nawras, Ali
    GASTROENTEROLOGY, 2013, 144 (05) : S637 - S637
  • [8] Outcome of continued infliximab therapy in Crohn's disease patients with response but without remission after one year of infliximab - a retrospective cohort study
    Buhl, Sine
    Borghede, Marta Kristina
    Brynskov, Jorn
    Steenholdt, Casper
    Rasmussen, Maria
    Ainsworth, Mark Andrew
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (08) : 930 - 937
  • [9] MAINTENANCE OF CLINICAL REMISSION IN CROHN'S DISEASE PATIENTS AFTER DISCONTINUATION OF LONG TERM TREATMENT WITH INFLIXIMAB: RESULTS OF A SINGLE CENTRE COHORT
    Monterubbianesi, R.
    Papi, C.
    Kohn, A.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E100 - E100
  • [10] Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study
    Chauvin, Armelle
    Le Thuaut, Aurelie
    Belhassan, Mehdi
    Le Baleur, Yann
    Mesli, Farida
    Bastuji-Garin, Sylvie
    Delchier, Jean Charles
    Amiot, Aurelien
    DIGESTIVE AND LIVER DISEASE, 2014, 46 (08) : 695 - 700
12345